Reduced expression of RASSF1A in esophageal and nasopharyngeal carcinomas significantly correlates with tumor stage

This publication has 17 references indexed in Scilit:

• TSLC1 Is a Tumor Suppressor Gene Associated with Metastasis in Nasopharyngeal Carcinoma
  Cancer Research, 2006
• THY1 is a candidate tumour suppressor gene with decreased expression in metastatic nasopharyngeal carcinoma
  Oncogene, 2005
• The Tumor Suppressor RASSF1A and MAP-1 Link Death Receptor Signaling to Bax Conformational Change and Cell Death
  Molecular Cell, 2005
• RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma
  International Journal of Cancer, 2004
• Critical tumor‐suppressor gene regions on chromosome 3P in major human epithelial malignancies: Allelotyping and quantitative real‐time PCR
  International Journal of Cancer, 2002
• The RASSF1A Tumor Suppressor Blocks Cell Cycle Progression and Inhibits Cyclin D1 Accumulation
  Molecular and Cellular Biology, 2002
• Epigenetic Inactivation of RASSF1A in Lung and Breast Cancers and Malignant Phenotype Suppression
  JNCI: Journal of the National Cancer Institute, 2001
• Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours
  Oncogene, 2001
• Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3
  Nature Genetics, 2000
• Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma
  1995